Wanhuida Intellectual Property

Follow

中国仿制药的发展现状分析

September 28 2018 仿制药是指与原研药在剂量、安全性、效力、质量、药效以及适应症上均相同的一种仿制药品。现代仿制药起源于1984 年9月美国国会签署通过的…

中国原研药的发展现状分析

October 24 2018 原研药的研发往往涉及多个学科,包括化学、生物化学、晶体学、药理学、药代动力学、药物设计等,其特点是研发风险高、耗时长及投资巨大…

最高院在判决中认为OEM产品上贴附标志不是对商标的使用

February 1 2016 最高院认为,委托加工产品上贴附的标志,既不具有区分所加工商品来源的意义,也不能实现识别该商品来源的功能,故其所贴附的标志不具有商标的属性,在产品上贴附标志的行为亦不能被认定为商标意义上的使用行为…

最新商标指导案例丨歌力思案:面对恶意注册的侵权抗辩与确权救济

March 23 2017 最高人民法院于2017年3月9日发布了第16批共10件指导性案例...

药物专利链接制度简介

January 4 2018 为了弥补药物原研企业的药物研发投入,促进新药创新,并且平衡原研药企与仿制药企之间的利益,…

Court rules against trademark squatter

June 28 2021 A recent case concerned a form of trademark squatting that involves the squatter filing numerous identical or similar marks, preferably in classes of…

SPC publishes six exemplary cases relating to punitive damages

June 21 2021 In China, decisions in which punitive damages are claimed and supported by the court are becoming increasingly frequent. The Supreme People's Court…

SPC releases judicial interpretation relating to punitive damages in IP cases

June 14 2021 In China, decisions in which punitive damages are claimed and supported by the court are becoming increasingly frequent. The Supreme People's Court…

How new Patent Law transforms patent litigation

June 7 2021 The fourth amendment to the Patent Law, which makes substantial changes to patent filing and enforcement, recently took effect. The amendment largely…

IP Court promulgates three important reports on 2020 IP cases

May 31 2021 In February 2021 the IP Court of the Supreme People's Court promulgated the Annual Report 2020, the Judicial Gist Synopsis 2020 and Ten Exemplary…